Close

Analyst Ratings for Jazz Pharmaceuticals (JAZZ)

JAZZ Rating Summary

JAZZ Price Target Summary

* Over Last 12-Mos
  |   Expand Research on JAZZ
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $184.58 (+73%) * Over Last 12-Mos
Rating Score: 8.4 / 10   Percentile Rank: 87%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/3/2024 Baird Joel Beatty New Coverage Outperform
(N/A)
160.00
(N/A)
123.00
(106.68)
-13.27% Details
11/27/2023 UBS
» Updated 3/1/2024
Ashwani Verma Downgrade Neutral
(Buy)
131.00
(135.00)
121.72
(106.68)
-12.36% Details